Hospital
Newark Wayne Community Hospital
Newark Wayne Community Hospital was paid $16.43M by Medicaid between Jan 2018 and Dec 2024, across 136 billing codes. Its largest line is 99284, emergency room visit (serious) — 17% of everything it billed.
33Billing provider infoNEWARK WAYNE COMMUNITY HOSPITAL
NEWARK, NY 14513
NEWARK, NY 14513
33aNPI1770671182assigned 10/11/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$16.43M
24GClaims207,181
24DCodes billed136
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in New York
Rank by total paid#67 of 231
Median peer was paid$561K
This provider vs. median29×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,886 | $459K | |
| 2019 | 11,352 | $975K | |
| 2020 | 31,253 | $2.47M | |
| 2021 | 41,679 | $3.20M | |
| 2022 | 45,379 | $3.59M | |
| 2023 | 44,334 | $3.56M | |
| 2024incomplete | 28,298 | $2.18M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 24,016 | 23,144 | $2.80M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 17% | 19,921 | 19,343 | $2.79M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 13,791 | 13,267 | $1.79M |
| 96361 | Intravenous infusion, hydration; each additional hour | 11% | 7,654 | 6,861 | $1.77M |
| 59025 | Fetal non-stress test | 4.0% | 3,435 | 2,066 | $663K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.9% | 2,211 | 2,187 | $648K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.1% | 1,731 | 1,700 | $503K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 2.7% | 1,827 | 1,807 | $441K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.5% | 2,854 | 2,797 | $414K |
| 80053 | Comprehensive metabolic panel | 2.1% | 14,128 | 12,977 | $348K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.9% | 1,550 | 1,507 | $309K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.7% | 5,706 | 5,551 | $274K |
124 more codes
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.7% | 4,007 | $272K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.6% | 901 | $263K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1.4% | 344 | $234K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.1% | 3,823 | $186K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.1% | 271 | $185K |
| 99215 | Doctor's office visit, returning patient (complex) | 1.1% | 1,503 | $175K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 1.1% | 558 | $173K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 1,154 | $130K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,653 | $130K |
| 76770 | <1% | 609 | $126K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 384 | $121K |
| 36415 | Collection of venous blood by venipuncture | <1% | 18,582 | $118K |
| 87631 | <1% | 1,852 | $114K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,677 | $109K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,591 | $96K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 1,122 | $74K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 943 | $61K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 350 | $54K |
| 97161 | <1% | 626 | $52K | |
| 76830 | Ultrasound, transvaginal | <1% | 1,184 | $46K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 933 | $46K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,241 | $45K |
| 86850 | <1% | 1,155 | $45K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 121 | $41K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,053 | $39K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 307 | $35K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 588 | $34K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 107 | $33K |
| 86901 | <1% | 1,213 | $32K | |
| 12001 | <1% | 69 | $30K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 332 | $29K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 109 | $29K |
| 87634 | <1% | 1,227 | $29K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 4,036 | $28K |
| G0378 | Hospital observation service, per hour | <1% | 117 | $26K |
| 86900 | <1% | 1,203 | $25K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 374 | $25K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 573 | $23K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,084 | $23K |
| 83880 | <1% | 654 | $21K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 13 | $20K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,543 | $20K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 51 | $17K |
| 93971 | <1% | 161 | $16K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 703 | $16K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 213 | $15K |
| 94060 | <1% | 219 | $12K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,520 | $11K |
| 71250 | <1% | 127 | $11K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,434 | $11K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 68 | $10K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,344 | $9K |
| 76801 | <1% | 78 | $9K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,917 | $8K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,193 | $8K |
| 94727 | <1% | 451 | $7K | |
| 80076 | <1% | 567 | $7K | |
| 72141 | <1% | 24 | $7K | |
| 94729 | <1% | 518 | $7K | |
| 81025 | <1% | 2,046 | $7K | |
| 71271 | <1% | 247 | $5K | |
| 85610 | <1% | 1,342 | $5K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 693 | $5K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 29 | $5K |
| 82803 | <1% | 146 | $5K | |
| 76536 | <1% | 220 | $5K | |
| 90715 | <1% | 155 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,372 | $5K |
| 72110 | <1% | 210 | $4K | |
| 71045 | Radiologic examination, chest; single view | <1% | 485 | $4K |
| 88304 | <1% | 54 | $4K | |
| 87081 | <1% | 947 | $4K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 72 | $4K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 120 | $4K |
| 70496 | <1% | 13 | $4K | |
| 84484 | <1% | 2,109 | $3K | |
| 74018 | <1% | 290 | $3K | |
| 80061 | Lipid panel | <1% | 254 | $3K |
| 77080 | <1% | 46 | $3K | |
| 80050 | General health panel | <1% | 78 | $2K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 12 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,177 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 69 | $2K |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 52 | $2K |
| 81001 | <1% | 1,700 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 249 | $1K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 20 | $1K |
| 85027 | <1% | 334 | $1K | |
| 84702 | <1% | 1,489 | $1K | |
| 76642 | <1% | 51 | $956.13 | |
| 83690 | <1% | 1,672 | $912.02 | |
| 87040 | <1% | 37 | $804.04 | |
| 83735 | <1% | 445 | $742.59 | |
| 81003 | <1% | 947 | $502.09 | |
| 87186 | <1% | 102 | $465.12 | |
| 73630 | <1% | 63 | $380.14 | |
| 73564 | <1% | 13 | $323.55 | |
| 76641 | <1% | 14 | $284.40 | |
| 73130 | <1% | 31 | $283.27 | |
| 73610 | <1% | 28 | $279.87 | |
| 87660 | <1% | 27 | $270.93 | |
| 87480 | <1% | 26 | $254.89 | |
| 87510 | <1% | 25 | $237.45 | |
| 84132 | <1% | 50 | $236.04 | |
| 82565 | <1% | 39 | $206.22 | |
| 82607 | <1% | 13 | $184.73 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,937 | $174.20 |
| 73030 | <1% | 13 | $145.78 | |
| 73110 | <1% | 15 | $127.54 | |
| 73502 | <1% | 14 | $126.78 | |
| 87077 | <1% | 43 | $123.25 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 771 | $113.53 |
| 80306 | <1% | 123 | $104.86 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 14 | $72.38 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,380 | $59.12 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 826 | $50.21 |
| 87430 | <1% | 59 | $44.37 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 593 | $40.23 |
| 86140 | <1% | 13 | $10.26 | |
| 85652 | <1% | 12 | $5.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 95 | $3.92 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 12 | $1.13 |
| 83605 | <1% | 14 | $0.47 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 36 | $0.05 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCRILLY, THOMAS (CFO/EXEC. VP)
| Provider | Location | Paid |
|---|---|---|
| Unity Linden Oaks Surgery Center, LLC | Rochester, NY | $390K |
| Rochester General Hospital | Rochester, NY | $145K |
| Newark-Wayne Community Hospital | Newark, NY | $13K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.